NCT02674997View on ClinicalTrials.gov

GAS-Hem Feasibility Study

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

August 5, 2016

Primary Completion Date

November 2, 2016

Study Completion Date

November 2, 2016

Conditions
Hemophilia A
Interventions
BIOLOGICAL

Factor VIII

Licensed Factor VIII products. Study is brand agnostic

Trial Locations (4)

61615

Bleeding and Clotting Disorders Institute, Peoria

97239

Oregon Health & Science University, Portland

V6Z 1Y6

St. Paul's Hospital, Vancouver

B3H 3G1

QEII Health Sciences Centre, Halifax

All Listed Sponsors
lead

Baxalta now part of Shire

INDUSTRY

NCT02674997 - GAS-Hem Feasibility Study | Biotech Hunter | Biotech Hunter